SMMT
Summit Therapeutics PLC
16.80$
+0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | |
| 100.0% | 79.6% | 43.9% | 29.4% | 53.6% | 2.2% | 768.2% | 58.8% | 17.1% | 4.9% | 1.3% | 0.0% | 4.0% | 2.6% | 0.7% | 0.0% | 0.5% | – | – | 431.1% | – | – | – | |
| 2,374.2% | 20.4% | 56.1% | 70.6% | 1.9% | 97.8% | -706.9% | 41.2% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 98.8% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | |
| 2,549.3% | 237.2% | 193.3% | 285.5% | 254.5% | 2,767.0% | 1,218.1% | 303.4% | 276.0% | 249.7% | 358.5% | 551.7% | 1,315.8% | 797.6% | 204.5% | 86.0% | 91.1% | 6,194.7% | 4,718.2% | 7,375.7% | – | – | – | |
| 2,400.6% | 35.4% | 189.3% | 42.6% | 85.3% | 1,465.3% | 1,268.1% | 362.5% | 87.0% | 82.2% | 105.3% | 196.2% | 362.2% | 348.4% | 84.2% | 28.4% | 21.6% | 2,236.3% | 1,305.2% | 3,793.3% | – | – | – | |
| 2,400.6% | 272.6% | 395.0% | 494.4% | 434.9% | 7,296.8% | 1,225.2% | 534.9% | 413.3% | 341.5% | 463.8% | 747.9% | 1,688.3% | 1,146.0% | 282.3% | 90.5% | -91.1% | 6,285.2% | 4,864.3% | 10,325.4% | – | – | – | |
| -2,400.6% | -252.4% | -339.0% | -423.8% | -388.5% | -7,198.9% | -3,047.6% | -1,270.0% | -422.3% | -241.5% | -363.8% | -647.9% | -1,588.3% | -1,046.0% | -182.3% | 9.4% | 35.2% | -11,392.7% | -4,764.3% | -10,225.4% | – | – | – | |
| 100.0% | 190.3% | 1.2% | 0.6% | 1.3% | 43.8% | 35.4% | 0.9% | 0.4% | 83.5% | 0.8% | 23.7% | 27.4% | 45.3% | 11.6% | 1.1% | 0.1% | 40.5% | 15.5% | 754.6% | – | – | – | |
| -2,300.6% | -62.0% | -229.1% | -339.4% | -364.1% | -7,081.1% | -3,078.7% | -775.4% | -421.7% | -240.9% | -363.3% | -671.7% | -1,810.7% | -1,081.9% | -168.8% | 15.9% | 11.6% | -9,902.3% | -4,897.8% | -11,174.8% | – | – | – | |
| -100.0% | -21.2% | -29.2% | -47.3% | -30.1% | -944.3% | -196.7% | -262.6% | -42.8% | -18.0% | 32.9% | -76.7% | -257.1% | -228.1% | -24.5% | -3.1% | -8.9% | -1,522.7% | -135.7% | -775.6% | – | – | – | |
| -2,300.6% | -40.7% | -200.0% | -292.1% | -334.1% | -12,109.6% | -1,769.2% | -1,004.6% | -379.0% | -223.0% | -330.4% | -603.0% | -1,572.0% | -899.5% | -142.3% | 19.0% | 11.6% | -6,127.6% | -4,762.1% | -11,174.8% | – | – | – | |
| -3,660.5% | -247.7% | -313.5% | -302.5% | -308.4% | -6,010.4% | -1,790.4% | -1,170.1% | -159.4% | -200.0% | -362.4% | -646.2% | -1,584.5% | -1,043.6% | -185.9% | 20.4% | 36.5% | -5,904.9% | -4,628.6% | -8,845.1% | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.